Pharmaceutical Industry Overview

It has estimated that in the field of medicinal chemistry more than $79 million in research funding has spent since 2008. A complete overview of drug designing process has come up with some crucial details that from year 2008 to 2013 the market has a growth with $ 198 billion and in further this rate may increases to $236 billion from year 2014 to 2019. Special emphasis is given on computational approaches for drug discovery along with salient features and applications of the software’s used in de-novo drug designing. In the future year of 2020, the revenue budget of drug designing or drug production reveals that the large drug companies are facing the expiry of patents on their best sellers. At the same time they are having trouble inventing new medicines, and this means that the drug industry’s sales may at best tread water and could face some steep drops. The point of market analysis is to see what happens after the immediate patent expirations, like the loss of Lipitor from highly reputed companies

  • Chemistry services and market
  • Regulations governing the industry.
  • Regulatory drug analysis and interpretation of analytical data
  • Industrial safety and health law
  • Globally harmonized system
  • Drug approvals
  • Submitting new chemical notifications and product registrations
  • Minimizing development and manufacturing cost
  • Immunogenicity of Biopharmaceuticals
  • Domestic substances list (DSL) and the non-domestic substances list (NDSL)

Related Conference of Pharmaceutical Industry Overview

Pharmaceutical Industry Overview Conference Speakers